Commentary on Mosaic Copy Number Variation in a Patient with Cerebral and Pulmonary Arteriovenous Malformations and Recurrent Epistaxis

Naif A M Almontashiri
DOI: https://doi.org/10.1093/clinchem/hvae128
IF: 12.114
2024-11-10
Clinical Chemistry
Abstract:Mosaic copy number variants (CNVs) pose diagnostic challenges as they are commonly missed or dismissed during the interpretation of the data generated by the next-generation sequencing (NGS) technologies (gene panels and whole-exome and whole-genome sequencing) because of low-read depth/coverage, below threshold allele fraction, or lack of reliable CNV callers (1). However, even for calling germline CNVs, in silico CNV calling is considered a screening not a diagnostic tool. Therefore, any detected CNV should be confirmed by an orthogonal method(s) such as droplet-digital PCR or quantitative PCR. Sometimes, testing additional tissues that are relevant to the phenotype of the patient is required.
medical laboratory technology
What problem does this paper attempt to address?